In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
Tampa Free Press on MSN6h
Biden-Harris FTC Takes Legal Action Over Insulin Price InflationFriday initiated legal action against the three largest prescription drug benefit managers (PBMs) in the U.S.—Caremark Rx, ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
LITTLE ROCK, Ark. – Arkansas Legislative Council members signed off on several measures Friday in a committee meeting – ...
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
FTC's action today is likely only the tip of the iceberg of necessary reforms to end PBMs' harmful business practices that have directly led to the lights going out for thousands of independent ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback